Evidence map›Paper›PMID 29382370›Full record

ArticleJournal of cardiothoracic surgery2018

Supraclavicular Subclavian access for Sapien Transcatheter aortic valve replacement- a novel approach.

Thom G Dahle, Nathaniel J Castro, Brian M Stegman, Jacob R Dutcher, John M Teskey, Wade T Schmidt, Daren S Danielson, Sara J Dezell, Virginia B Daniels, Daniel J Tiede

Open access · goldAbstract read
In one paragraph

Article in Journal of cardiothoracic surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. SCAI Expert Consensus Statement on Alternative Access for Transcatheter Aortic Valve Replacement.Journal of the Society for Cardiovascular Angiography & Interventions · 2025
    Article
  2. Article
  3. The Transaxillary ApproachFrontiers in cardiovascular medicine · 2021
    Article
  4. Article
  5. Review
  6. Alternate Access for TAVI: Stay Clear of the Chest.Interventional cardiology (London, England) · 2018
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Thom G DahleCentraCare Heart & Vascular Center, St Cloud Hospital, 1200 Sixth Ave N, St Cloud, MN, 56303-1901, USA. tdahlemd@gmail.com.
Nathaniel J CastroCentraCare Heart & Vascular Center, St Cloud Hospital, 1200 Sixth Ave N, St Cloud, MN, 56303-1901, USA.
Brian M StegmanCentraCare Heart & Vascular Center, St Cloud Hospital, 1200 Sixth Ave N, St Cloud, MN, 56303-1901, USA.
Jacob R DutcherCentraCare Heart & Vascular Center, St Cloud Hospital, 1200 Sixth Ave N, St Cloud, MN, 56303-1901, USA.
John M TeskeyCentraCare Heart & Vascular Center, St Cloud Hospital, 1200 Sixth Ave N, St Cloud, MN, 56303-1901, USA.
Wade T SchmidtCentraCare Heart & Vascular Center, St Cloud Hospital, 1200 Sixth Ave N, St Cloud, MN, 56303-1901, USA.
Daren S DanielsonCentraCare Heart & Vascular Center, St Cloud Hospital, 1200 Sixth Ave N, St Cloud, MN, 56303-1901, USA.
Sara J DezellCentraCare Heart & Vascular Center, St Cloud Hospital, 1200 Sixth Ave N, St Cloud, MN, 56303-1901, USA.
Virginia B DanielsCentraCare Heart & Vascular Center, St Cloud Hospital, 1200 Sixth Ave N, St Cloud, MN, 56303-1901, USA.
Daniel J TiedeCentraCare Heart & Vascular Center, St Cloud Hospital, 1200 Sixth Ave N, St Cloud, MN, 56303-1901, USA.
St. Cloud Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWithin the trans-subclavian approach, procedural techniques can vary widely, and reported access generally refers to an infraclavicular axillary approach. We describe and report the use of a novel supraclavicular true subclavian approach for transcatheter aortic valve replacement (TAVR) exclusively for implantation of Sapien 3 valves. CASE PRESENTATION: We report our first five consecutive patients undergoing TAVR with a Sapien 3 valve using a standardized subclavian approach at a single center. In-hospital and 30-day complications were reported. The use of this approach resulted in successful implantation in 100% of patients in a safe manner with 0% mortality, stroke, and vascular injury during hospitalization and at 30 day follow-up. The in-hospital pacemaker implantation rate was 20%. The average length of stay was 3 days.

conclusionsTAVR with Sapien implant can be safely performed with a standardized supraclavicular subclavian approach in patients with unfavorable femoral access.

Indexed as

Aged, 80 and overAortic ValveAortic Valve StenosisFemaleHeart Valve ProsthesisHumansLength of StayMalePostoperative ComplicationsSubclavian VeinTranscatheter Aortic Valve ReplacementTreatment OutcomeAorticSapienSubclavianSupraclavicularTranscatheter

Identifiers

PMID29382370
PMCPMC5791360
OpenAlexW2789852348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.